24 10, 2024

Qkine strengthens its support for the cellular agriculture through provision of high quality food grade growth factors

2024-10-24T21:40:13+00:00October 24th, 2024|cellular agriculture, News|

Qkine announces the provision of a new range of high quality food grade growth factors as part of our commitment to driving innovation in the functional recombinant growth factor supply chain for emerging sectors including cultivated meat, fish, fat and dairy.

24 10, 2024

National Alternative Protein Innovation Centre (NAPIC) launched

2024-10-24T10:31:52+00:00October 24th, 2024|Blog, cellular agriculture, News|

NAPIC is a £38m centre dedicated to developing acceptable and planet-friendly alternatives to animal proteins led by researchers from the University of Leeds, James Hutton Institute, University of Sheffield and Imperial College London.

23 10, 2024

Pep Talk October 2024

2024-10-23T13:49:34+00:00October 23rd, 2024|Awards, News, newsletter, Resources|

In this edition, we are excited to announce a price freeze moving into 2025, our win of Scale-up of the Year in the Cambridge Business Awards. We also share our latest hematopoietic stem cells blog, new products IL-2 and activin E PLUS and a new application note on growth factor stability.

4 10, 2024

Qkine integrates the latest advancement in fill-finish automation into its recombinant protein manufacturing process

2024-10-07T14:24:03+00:00October 4th, 2024|Blog, News, quality|

Our latest investment in our mission at Qkine to produce the highest quality growth factors for research. The most state-of-the-art automated system which fills, labels and caps vials with minimal manual intervention.

3 10, 2024

Qkine winners of Cambridge Business Awards 2024 – Scale-up of the Year

2024-10-03T08:34:12+00:00October 3rd, 2024|Awards, News, Press Release|

Qkine wins 'Scale-up of the Year' at the 2024 Cambridge Independent Business Awards On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some of the most impressive Cambridge business leaders for an exciting evening of networking and entertainment at the [...]

12 09, 2024

Qkine collaboration with the Bertero Lab, Heart Engineering and Developmental Genomics et al. (HEDGe), University of Turin, Italy

2024-09-12T11:52:48+00:00September 12th, 2024|Blog, News, stem cells|

This recent publication in collaboration with Qkine focusses on the optimization of home-brew media for the maintenance of human induced pluripotent stem cells (hiPSCs), using Qkine growth factors to allow cost-effective, practical, and reproducible culture of hiPSCs. Qkine thermostable tag-free FGF2-G3 proteins were found to be highly bioactive, necessitating an 8-fold reduction in concentration for the short (145 aa) form of FGF2-G3 in the optimized media.

2 09, 2024

Qkine announces its sales distribution agreement with Scientist.com Product Hub Marketplace

2024-09-10T14:50:16+00:00September 2nd, 2024|News, Press Release|

Qkine is pleased to announce a new global sales distribution agreement with AI driven digital research platform Scientist.com on their Product Hub Marketplace.

29 08, 2024

Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer

2024-09-05T09:20:39+00:00August 29th, 2024|News, Press Release|

Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and Paul Grafham as Chief Financial Officer. With years of experience working with fast-growing biotechs and life science [...]

16 08, 2024

Qkine is pleased to announce that it has been recertified with the international standard ISO 9001:2015 by globally respected UKAS-accredited BSI

2024-10-10T08:20:51+00:00August 16th, 2024|Awards, cellular agriculture, News, Press Release, quality|

Qkine is pleased to announce that it has successfully been recertified with the international standard ISO 9001:2015 by the globally respected UKAS accredited BSI, giving enhanced confidence in the assessment of best practices. This standard shows our dedication to raising the standard of bioactive proteins through implementation of continual improvement, scientific innovation and exceptional scientific and customer support

Go to Top